Abstract
ABSTRACT: We injected 3-day-old (neonatal), 8-day-old (infant), and 8-wk-old (adult) Sprague-Dawley rats with monocrotaline to examine the effect of a toxic agent at various stages of lung development. Two and four weeks after injection the rats were killed and the heart and lungs removed: the right and left ventricles were separated and weighed, the pulmonary artery was injected with barium-gelatin, and the lung was fixed in the inflated state. Morphometric techniques were applied to assess lung volume, alveolar size and number, and arterial size, muscularity, and concentration relative to alveolar. Rats injected with monocrotaline in the neonatal period did not survive to 3 wk. After 2 wk, there was no significant right ventricular hypertrophy and pulmonary vascular changes were no worse than in the other rat groups injected with monocrotaline, but alveolar development was severely impaired; less than one-third the normal number was present. Rats injected with monocrotaline in infancy had normal alveolar development. After 2-wk, the arterial changes, i.e. extension of muscle into peripheral arteries, medial hypertrophy of muscular arteries, and decreased arterial concentration relative to alveolar were similar to those observed in adult rats. After 4 wk, there was a decrease in medial hypertrophy associated with growth in artery size and only a lack of regression of right ventricular weight. In adult rats, after 4 wk medial hypertrophy became progressively more severe, the arterial concentration relative to alveolar decreased further, and right ventricular hypertrophy developed. Thus, exposure to a toxic agent in the newborn period may have a critical effect on alveolar development, whereas arterial changes induced by a toxic agent during infancy may regress if there is potential for growth of the pulmonary vascular bed.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Todd, L., Mullen, M., Olley, P. et al. Pulmonary Toxicity of Monocrotaline Differs at Critical Periods of Lung Development. Pediatr Res 19, 731–737 (1985). https://doi.org/10.1203/00006450-198507000-00019
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-198507000-00019
This article is cited by
-
Pathophysiology of Infantile Pulmonary Arterial Hypertension Induced by Monocrotaline
Pediatric Cardiology (2015)
-
Fluorescent microangiography (FMA): an improved tool to visualize the pulmonary microvasculature
Laboratory Investigation (2006)
-
Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep
Gene Therapy (1999)